---
category: news
title: "IQ-AI eyes start of clinical trials in 2022 after finding capsule supplier"
excerpt: "StockMarketWire.com - IQ-AI said it was looking forward to start of clinical trials after finding a supplier to encapsulate the drug candidate. Production of the capsules was now underway and IQ-AI anticipated the trial would commence in February 2022."
publishedDateTime: 2021-12-17T08:24:00Z
originalUrl: "https://www.stockmarketwire.com/article/7224648/IQ-AI-eyes-start-of-clinical-trials-in-2022-after-finding-capsule-supplier.html"
webUrl: "https://www.stockmarketwire.com/article/7224648/IQ-AI-eyes-start-of-clinical-trials-in-2022-after-finding-capsule-supplier.html"
type: article
quality: 35
heat: 35
published: false

provider:
  name: StockMarketWire
  domain: stockmarketwire.com

topics:
  - AI

images:
  - url: "https://www.stockmarketwire.com/images/youinvest-logo.png"
    width: 800
    height: 315
    isCached: true

secured: "PzMAi96MxbVrnRz9U4K/hxwxVNE695AKizdZ4ev+QCdwMUraHy3IhCclA8CrzIzH2LLfzEI05TZECByco7pIoIr1kVf/uvbPx090ubJBU1MKTD24BWhnRBWF7q44+mVTraWtJRUKzRwacGKGKMT4Dyl/vegG+ZVZ6RoXU+B8nOELyganlWIqzEtCiFgblQ8MVimC1Nw0KKJEFKwFrqF9R1BecwrKbSRARSxuXdZZ6O9O64jD5fUiBdoWkfMVe3StShi6CMgbRTMZw3G4/Sm+wtDYMmqJ+7zKR4cFa3HvfXd8cHiJz8vifOPGLSdt65/+ibwCnuvdUnKMngFw4smCj7gJtOEcvwvnOtJZuRQB6rw=;J15VGgurSpxviyfyZKHy+Q=="
---

